Ursodeoxycholic acid treatment in isolated chronic graft-vs.-host disease of the liver

Clinical Transplantation

Volumn 19, Issue 6, 2005, Pages 798-803

  Arat, Mutlu ^a   Idilman, Ramazan ^a   Soydan, Ender Akcaglayan ^a   Soykan, Irfan ^a   Erden, Esra ^a   Karayalçin, Selim ^a   Akan, Hamdi ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

Allogeneic hematopoietic cell transplantation; Cholestatic liver diseases; Chronic graft vs. host disease; Ursodeoxycholic acid

Indexed keywords

ALKALINE PHOSPHATASE; AMINOTRANSFERASE; BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; FLUDARABINE; GAMMA GLUTAMYLTRANSFERASE; LIVER ENZYME; METHOTREXATE; TAUROURSODEOXYCHOLIC ACID; THYMOCYTE ANTIBODY; URSODEOXYCHOLIC ACID;

ADOLESCENT; ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CHRONIC DISEASE; CLINICAL ARTICLE; CLINICAL EXAMINATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; LABORATORY TEST; LIVER BIOPSY; LIVER DISEASE; LIVER FUNCTION TEST; LONG TERM CARE; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PRURITUS;

ADOLESCENT; ADULT; ASPARTATE AMINOTRANSFERASES; BILIRUBIN; CHOLAGOGUES AND CHOLERETICS; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LIVER DISEASES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TRANSPLANTATION CONDITIONING; URSODEOXYCHOLIC ACID;

EID: 28644439303     PISSN: 09020063     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2005.00424.x     Document Type: Article

References (15)

1. Akpek G, Boitnott JK, Lee LA et al. Hepatitic-variant of graft-versus-host disease after donor lymphocyte infusion. Blood 2002: 100: 3903.
2. Arai S, Lee LA, Vogelsang G. A systematic approach to hepatic complications in hematopoietic stem cell transplantation. J Hematother Stem Cell Res 2002: 11: 215.
3. Yau JC, Zander AR, Srigley JR et al. Chronic graft-versus-host disease complicated by micronodular cirrhosis and esophageal varices. Transplantation 1986: 41: 129.
4. Knapp AB, Crawford JM, Rappepart JM, Gollan JL. Cirrhosis as a consequence of graft-versus-host disease. Gastroenterology 1987: 92: 513.
5. Goulis J, Leandro G, Burroughs AK. Randomized controlled trials of ursodeoxycholic acid therapy for primary biliary cirrhosis: a meta analysis. Lancet 1999: 354: 1053.
6. Kowdley KV. Ursodeoxycholic acid therapy in hepatobiliary disease. Am J Med 2000: 108: 481.
7. Rubin RA, Kowalski TE, Khandelwal M, Malet PF. Ursodiol for hepatobiliary disorders. Ann Intern Med 1994: 121: 207.
8. Fried RH, Murakami CS, Fisher LD, Willson RA, Sullivan KM, McDonald GB. Ursodeoxycholic acid treatment of refractory chronic graft-versus-host disease of the liver. Ann Intern Med 1992: 116: 624.
9. Shulman HM, Sullivan KM, Weiden PL et al. Chronic graft-versus-host syndrome in man: a long-term clinicopathologic study of 20 Seattle patients. Am J Med 1980: 69: 204.
10. Paumgartner G, Beuers U. Ursodeoxycholic acid in cholestatic liver disease: mechanisms of action and therapeutic use revisited. Hepatology 2002: 36: 525.
11. Lazaridis KN, Gores GJ, Lindor KD. Ursodeoxycholic acid "mechanism, action and clinical use in hepatobiliary disorders". J Hepatol 2001: 35: 134.
12. Lim AG, Jazrawi RP, Northfield TC. The ursodeoxycholic acid story in primary biliary cirrhosis. Gut 1995: 37: 301.
13. Calmus Y, Gane P, Rouger P, Poupon R. Hepatic expression of class I and class II major histocompatibility complex molecules in primary biliary cirrhosis: effect of ursodeoxycholic acid. Hepatology 1990: 11: 12.
14. Roberts MM, To LB, Gillis D et al. Immune reconstitution following peripheral blood stem cell transplantation, autologous bone marrow transplantation and allogeneic bone marrow transplantation. Bone Marrow Transplant 1993: 12: 469.
15. Talmadge JE, Reed E, Ino K et al. Rapid immunologic reconstitution following transplantation with mobilized peripheral blood stem cells as compared to bone marrow. Bone Marrow Transplant 1997: 19: 161.